Forex Market News Today
  • Home
  • News
  • LiveHourly
  • Markets
  • Stock
  • Business
  • Economy
  • World
  • Politics
  • Energy
  • exchange
  • companies
No Result
View All Result
Forex Market News Today
Home News

VOYAGER THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & …

1 month ago
in News
2 min read
VOYAGER THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & …
Share on FacebookShare on Twitter


LEAD PLAINTIFF DEADLINE IS MARCH 24, 2021

NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a announces that a federal securities class action lawsuit has been filed against Voyager Therapeutics, Inc. (“Voyager” or the “Company”) (NASDAQ: VYGR) in the United States District Court for the Eastern District of New York on behalf of a class consisting of all investors that purchased or otherwise acquired Voyager securities between June 1, 2017 and November 9, 2020, inclusive (the “Class Period”).

All investors who purchased shares of Voyager Therapeutics, Inc. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website, www.whafh.com.

If you have incurred losses in the  shares of Voyager Therapeutics, Inc., you may, no later than March 24, 2021, request that the Court appoint you lead plaintiff of the proposed class.  Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of Voyager Therapeutics, Inc. 

CLICK HERE TO JOIN CASE

Voyager, a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases.  Included in the Company’s preclinical programs is VY-HTT01 for Huntington’s Disease. 

On June 1, 2017, Voyager issued a press release announcing that it had selected VY-HTT01 as a lead clinical candidate for the treatment of Huntington’s disease.  The press release also indicated that, [p]reclinical pharmacology and toxicology studies [were] underway with VY-HTT01 to support filing of an investigational new drug (IND) application in 2018.”

In September 2020, Voyager submitted an investigational new drug (“IND”) application for VY-HTT01 for the treatment of Huntington’s disease to the U.S. Food and Drug Administration (“FDA”).

On October 12, 2020, Voyager issued a press release disclosing that it “has received feedback from the U.S. Food and Drug Administration (FDA) on the Investigational New Drug (IND) submission for VY-HTT01 for the treatment of Huntington’s disease.”  Specifically, Voyager advised investors that it “has
been notified that the IND was placed on clinical hold pending the resolution of certain chemistry, manufacturing and controls (CMC) matters.”

Then, on November 9, 2020, Voyager issued a press release announcing the Company’s third quarter 2020 financial results and corporate updates.  In the press release, the Company disclosed that, with respect to its IND application for VY-HTT01, “Voyager recently received written feedback from the FDA
requesting additional information on specific CMC topics, including drug-device compatibility and drug substance and product characterization.”

On this news, Voyager’s stock price fell $2.60 per share, or 23.21%, to close…



Go to the news source: VOYAGER THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & …

Tags: ActionAdlerAlertFreemanHaldensteinINCCLASSTherapeuticsVOYAGERwolf
Previous Post

Silver May Rally Above $39 On Range Breakout

Next Post

Economics News: Stock Market Live Updates

Related Posts

Markets Await UK Budget Plan
News

Markets Await UK Budget Plan

by Forex News
March 4, 2021
0

It is also expected that the government will make every effort to restore the economy. As markets await the...

Read more
UK Services PMI and Budget in Spotlight
News

UK Services PMI and Budget in Spotlight

by Forex News
March 3, 2021
0

The GBP/USD is wavering ahead of the UK services PMI numbers and annual budget reading. The GBP to USD...

Read more
Euro sharpens decline to four-week low
News

Euro sharpens decline to four-week low

by Forex News
March 2, 2021
0

Euro fell in European trade on Tuesday for the third straight session against dollar, marking four-week lows ahead of...

Read more
U.S. Stocks Gap Higher To Open March
News

U.S. Stocks Gap Higher To Open March

by Forex News
March 1, 2021
0

U.S. stocks have opened March with a bang, gapping higher during today’s session. At the midway point of the...

Read more
CEO & Whole Time Director Yogesh Malhotra Just Bought 47% More Shares In Gravita…
News

CEO & Whole Time Director Yogesh Malhotra Just Bought 47% More Shares In Gravita…

by Forex News
March 1, 2021
0

Even if it's not a huge purchase, we think it was good to see that Yogesh Malhotra, the CEO...

Read more
Should You Be Adding ADDvise Group (STO:ADDV A) To Your Watchlist Today?
News

Should You Be Adding ADDvise Group (STO:ADDV A) To Your Watchlist Today?

by Forex News
February 28, 2021
0

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a...

Read more
Is Now The Time To Look At Buying Inta Bina Group Berhad (KLSE:INTA)?
News

Calculating The Intrinsic Value Of AECOM (NYSE:ACM)

by Forex News
February 27, 2021
0

In this article we are going to estimate the intrinsic value of AECOM (NYSE:ACM) by projecting its future cash...

Read more
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
News

Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants

by Forex News
February 26, 2021
0

CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a...

Read more
New York and Tether Conclude a Settlement
News

New York and Tether Conclude a Settlement

by Forex News
February 26, 2021
0

USDT/USD has incrementally traded higher as a settlement has been reached between New York and Tether. Advertisement USDT/USD is...

Read more
NZD/USD Forecast: Most Overbought Since December
News

NZD/USD Forecast: Most Overbought Since December

by Forex News
February 25, 2021
0

The NZD/USD price is in a strong upsurge as investors react to the latest RBNZ interest rate decision and...

Read more
Next Post
Economics News: Stock Market Live Updates

Economics News: Stock Market Live Updates

Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Latest Forex News

Texas freeze pushes U.S. gasoline prices higher

Texas freeze pushes U.S. gasoline prices higher

2 weeks ago
Is Beyond International (ASX:BYI) Weighed On By Its Debt Load?

Earnings Update: Here’s Why Analysts Just Lifted Their Live Nation Entertainment…

4 days ago
Dow Jones Futures: Stock Market Falls From Highs, As Bitcoin Plunges; Tesla Dive…

Dow Jones Futures: Stock Market Falls From Highs, As Bitcoin Plunges; Tesla Dive…

2 months ago
Are stock investors too complacent about a full-scale blowup between China and t…

Are stock investors too complacent about a full-scale blowup between China and t…

3 months ago

Today Market News

Saudis, Russia Discuss Joint Oil Output Raise Ahead of OPEC Meeting
Economy

Saudis, Russia Discuss Joint Oil Output Raise Ahead of OPEC Meeting

March 4, 2021
China’s Inner Mongolia Declares War on Crypto Mining – Bloomberg Markets and Fin…
Economy

China’s Inner Mongolia Declares War on Crypto Mining – Bloomberg Markets and Fin…

March 4, 2021
California inmate charged with unemployment benefits fraud
Economy

California inmate charged with unemployment benefits fraud

March 4, 2021
Sweden: Terrorism eyed after ax attack injures 8
World

Sweden: Terrorism eyed after ax attack injures 8

March 4, 2021
Rupee slumps 27 paise to 72.99 against US dollar in early trade
Live

Rupee slumps 27 paise to 72.99 against US dollar in early trade

March 4, 2021
Oil extends gains on prospect of OPEC+ sticking with supply cuts
Economy

Oil extends gains on prospect of OPEC+ sticking with supply cuts

March 4, 2021
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • DMCA
  • CCPA

© 2020 Siteofforex.com

No Result
View All Result
  • Home
  • News
  • Live
  • Markets
  • Stock
  • Business
  • Economy
  • World
  • Politics
  • Energy
  • exchange
  • companies

© 2020 Siteofforex.com

wpDiscuz